This is a routine sell-to-cover transaction for tax purposes with no directional signal. Monitor for any larger insider sales or changes in officer holdings in future Form 4 filings.
VIR drugs
VIR drug pipeline →How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+5- T+0 · Nov 2 $11.00entry
- T+1 · 14d ago +2.00%α +1.70% · $11.22
- T+5 · 8d ago +24.05%α +23.97% · $13.65
- T+10 · todayOpen
- T+20 · in 14d Pending
- T+60 · in 2mo Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Vanina de Verneuil, an officer of Vir Biotechnology, filed a Form 144 notice of intent to sell 1,343 shares of common stock, with an approximate market value of $15,222. The sale is described as a 'sell-to-cover' transaction to satisfy tax withholding obligations arising from the settlement of a vested equity award. The filing is routine and immaterial relative to the company's $2.0B market cap.
Key Facts
- Filer: Vanina de Verneuil, an officer of Vir Biotechnology
- Proposed sale of 1,343 shares of common stock
- Approximate value: $15,221.96
- Sale is a sell-to-cover for tax obligations on a vested equity award
- Shares to be sold on or about 2026-11-02 on Nasdaq
- Broker: Fidelity Brokerage Services LLC
Financial Impact
1,343 shares at ~$15,222 total, representing less than 0.001% of the company's $2.0B market cap
Risk Factors
- Form 144 is only an intent to sell; the actual sale may not occur
- No other insider sales or context provided to suggest broader insider sentiment
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001959173-26-007634 |
| Document: 0001959173-26-007634-index.html | 0001959173-26-007634 |
| Document: 0001959173-26-007634.txt | 0001959173-26-007634 |
Track record
36 reports on VIR
4 of 8 bullish or bearish reports moved the stock their way by T+5. Best: +29.79% at T+5 after the Nov 6, 2026 report. 5 of 9 went positive at some point.
Filters
- Nov 16, 2026today 424B5 Bearish 5/10 Entry price pending
- Nov 13, 20263d ago 8-K Bearish 5/10 Entry $9.92 Now $9.58 +3.43% settles Nov 23
- Nov 12, 20264d ago 424B5 Bearish 5/10 Entry $9.96 Now $9.58 +3.82% settles Nov 20
- Nov 12, 20264d ago S-3ASR Neutral 3/10 Entry $9.96 Now $9.58 −3.82% settles Nov 20
- Nov 10, 20266d ago SC 13G Neutral 3/10 Entry $13.15 Now $9.58 −27.15% settles Nov 17
- Nov 9, 20267d ago 8-K Bullish 6/10 Entry $13.65 to $9.58 Now $9.58 −29.79% ▼ −29.79% −28.10% vs SPY
- Nov 6, 202610d ago SC 13D/A Bearish 5/10 Entry $13.65 to $9.58 Now $9.58 +29.79% ▲ +29.79% +28.10% vs SPY
- Nov 4, 202612d ago 8-K Neutral 5/10 Entry $11.02 to $12.12 Now $9.58 −13.07% ▲ +9.98% +6.69% vs SPY
- Nov 3, 202613d ago 144 Neutral 2/10 Entry $11.22 to $13.15 Now $9.58 −14.62% ▲ +17.20% +17.79% vs SPY
- Nov 2, 202614d ago 144 Neutral 1/10 Viewing Entry $11.00 to $13.65 Now $9.58 −12.91% ▲ +24.05% +23.97% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers